BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 17540313)

  • 1. [Alport syndrome or progressive hereditary nephritis with hearing loss].
    Gubler MC; Heidet L; Antignac C
    Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Familial hematuric nephropathies].
    Gubler MC
    Rev Prat; 1997 Sep; 47(14):1545-9. PubMed ID: 9366112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renal lesions of Alport syndrome.
    Heidet L; Gubler MC
    J Am Soc Nephrol; 2009 Jun; 20(6):1210-5. PubMed ID: 19470679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N; Pan X; Ren H; Dong D
    Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical spectrum of type IV collagen mutations.
    Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
    Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
    Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
    J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular genetics of Alport syndrome].
    Yamazaki H; Saito A; Nakagawa Y; Arakawa M
    Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
    Maziers N; Dahan K; Pirson Y
    Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Collagen IV (alpha3-alpha4) nephropathy].
    Torra R; Tazón B; Ars E; Ballarín J
    Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.
    Garcia-Torres R; Cruz D; Orozco L; Heidet L; Gubler MC
    Nephrologie; 2000; 21(1):9-12. PubMed ID: 10730274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alport syndrome and thin basement membrane nephropathy.
    Thorner PS
    Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
    Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
    Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
    Ilan T; Shohat T; Tobar A; Magal N; Yahav M; Halpern GJ; Rechavi G; Shohat M
    Isr Med Assoc J; 2001 Jul; 3(7):488-91. PubMed ID: 11791413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
    Kashtan CE
    Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.